Alnylam Pharmace. buy WatchMen
Start price
16.10.19
/
50%
€73.50
Target price
09.02.20
-
Performance (%)
54.50%
End price
09.02.20
€113.56
Summary
This prediction ended on 09.02.20 with a price of €113.56. With a performance of 54.50% the BUY prediction by WatchMen was a big success. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 1.745% | 1.745% | 22.960% | 48.924% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.